2025-2026 peer-reviewed research described protocols for generating hiPSC-derived dermal papilla cells and testing their conditioned medium as a cell-free regenerative therapy, and for fabricating small dermal-papilla-cell spheroids that induced hair shaft formation when injected into nude mice.
- Lab
- Phase 1
- Phase 2
- Phase 3
- Approved
Lab / animal stage
How it works
Lab-grown dermal papilla cells (the signalling cells at the base of hair follicles), or their secreted factors ('secretome'/conditioned media), injected or applied to reawaken miniaturized follicles and induce new hair growth.
Results so far
No human efficacy data — results are limited to animal (nude mouse) and in-vitro models.
What's next
No human trial timeline publicly stated for these specific academic programs.
In India
A separate, unrelated allogenic mesenchymal stem cell (MSC) trial for AGA was identified as being run by the National Institute of Blood and Marrow Transplant in Pakistan (not India) — included here only to flag it is NOT an Indian trial, despite regional proximity.
Sources
- Journal paper ↗ (accessed 2026-10-17)
- Journal paper ↗ (accessed 2026-10-17)
- Trial registry ↗ (accessed 2026-10-17)
What to do today: treatments in development aren't a reason to wait. Ask a dermatologist about the options that work now, such as minoxidil and, for men, finasteride.
Discussion
Share your experience or ask a question. New members' posts are reviewed before they appear.